CCEL

Cryo-Cell International Inc

Add to Watchlist

Advanced Chart

5.010

+0.060(+1.210%)

Overview
Forecast
Valuation

Line

Candle

YTD

High

5.0099

Open

4.970

VWAP

4.98

Vol

3.61K

Mkt Cap

40.49M

Low

4.940

Amount

18.00K

EV/EBITDA(TTM)

9.20

Total Shares

8.10M

44.98M

EV/OCF(TTM)

6.14

P/S(TTM)

1.26

Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 500,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at this technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

8.03M

+0.06%

-0.040

-84.28%

8.10M

+0.41%

-0.040

-127.97%

8.04M

-0.02%

-0.040

-141.61%

Estimates Revision

The market is revising Upward the revenue expectations for Cryo-Cell International, Inc. (CCEL) for FY2025, with the revenue forecasts being adjusted by 0.27% over the past three months. During the same period, the stock price has changed by -32.48%.

Revenue Estimates for FY2025

Revise Upward

+0.27%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-25%

In Past 3 Month

Stock Price

Go Down

-32.48%

In Past 3 Month

1 Analyst Rating

69.66% Upside

Wall Street analysts forecast CCEL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CCEL is 8.50 USD with a low forecast of 8.50 USD and a high forecast of 8.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

69.66% Upside

Current: 5.010

Low

8.50

Averages

8.50

High

8.50

69.66% Upside

Current: 5.010

Low

8.50

Averages

8.50

High

8.50

Maxim Group

Allen Klee

Strong Buy

Maintains

$9 → $8.5

2025-03-04

Reason

Maxim Group

Allen Klee

Price Target

$9 → $8.5

2025-03-04

Maintains

Strong Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Cryo-Cell International Inc (CCEL.A) is -32.93, compared to its 5-year average forward P/E of 24.14. For a more detailed relative valuation and DCF analysis to assess Cryo-Cell International Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

24.14

Current PE

-32.93

Overvalued PE

122.53

Undervalued PE

-74.25

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

11.79

Current EV/EBITDA

13.49

Overvalued EV/EBITDA

21.76

Undervalued EV/EBITDA

1.82

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

1.20

Current PS

1.24

Overvalued PS

2.10

Undervalued PS

0.30

Financials

Annual

Quarterly

FY2025Q1

YoY :

+1.49%

7.97M

Total Revenue

FY2025Q1

YoY :

+29.41%

1.06M

Operating Profit

FY2025Q1

YoY :

-49.15%

282.86K

Net Income after Tax

FY2025Q1

YoY :

-57.14%

0.03

EPS - Diluted

FY2025Q1

YoY :

-209.50%

892.01K

Free Cash Flow

FY2025Q1

YoY :

+0.87%

72.69

Gross Profit Margin - %

FY2025Q1

YoY :

-165600.00%

16.55

FCF Margin - %

FY2025Q1

YoY :

-49.86%

3.55

Net Margin - %

FY2025Q1

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

0.0

Volume

6-9

Months

0.0

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

0.0

Volume

Months

6-9

0.0

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

CCEL News & Events

Events Timeline

2025-04-15 (ET)

2025-04-15

09:18:14

Cryo-Cell reports Q1 EPS 3c vs. 7c last year

2025-02-28 (ET)

2025-02-28

17:07:02

Cryo-Cell reports FY24 EPS 5c vs ($1.14) last year

News

8.0

05-08Newsfilter

Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend

4.0

03-04Benzinga

Maxim Group Maintains Buy on Cryo-Cell International, Lowers Price Target to $8.5

9.5

02-28Businesswire

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2024

People Also Watch

FAQ

What is Cryo-Cell International Inc (CCEL) stock price today?

The current price of CCEL is 5.0099 USD — it has increased 1.21 % in the last trading day.

CCEL

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

CCEL News & Events

Events Timeline

News

People Also Watch

FAQ

What is Cryo-Cell International Inc (CCEL) stock price today?

What is Cryo-Cell International Inc (CCEL)'s business?

What is the price predicton of CCEL Stock?

What is Cryo-Cell International Inc (CCEL)'s revenue for the last quarter?

What is Cryo-Cell International Inc (CCEL)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Cryo-Cell International Inc (CCEL)'s fundamentals?

How many employees does Cryo-Cell International Inc (CCEL). have?

What is Cryo-Cell International Inc (CCEL) market cap?